Replies to post #198681 on Avid Bioservices Inc (CDMO)

[biopharm]

Dmitry Gabrilovich : Peregrine Pharmaceuticals KOL : International Conference on Immunochemotherapy

The very long chain of posts covering all areas of Dmitry Gabrilovich and his expert view on MDSC's continues and how they are directly related to immunotherapy and yes, eventually will be completely all tied right into Bavituximab and Peregrine Pharmaceuticals.

For now though... pieces of the puzzle, including some interesting speakers coming up here in April, including Peregrine KOL Dmitry Gabrilovich.

------------------------------------------------------

International Conference on Immunochemotherapy

April 16-17, 2015

Lankenau Institute for Medical Research |
Philadelphia, USA |

http://10times.com/international-conference-on-immunochemotherapy/speakers

[biopharm]

Dmitry Gabrilovich : Peregrine Pharmaceuticals KOL : Video =48:53 in length ....

You got PPHM ? : )

You know about Dmitry Gabrilovich?

Follow this chain of posts all the way back to the day Peregrine Pharmaceuticals brought Dmitry on board... back on Dec 10, 2013 and you will see why MDSC's are relevant and all interconnected to flipped PS.

I don't know what the rush is though.... don't we have till 2016 or 2017 ? : )

Dmitry I. Gabrilovich: Regulation of Immune Response in Cancer by Myeloid Cells

19 November

Speaker: Dmitry I. Gabrilovich, Christopher M. Davis See Professor, The Wistar Institute, Philadelphia, USA.

Host: Anna Martner [e-mail]

Two open lectures are Offered on November 19 in collaboration between Sahlgrenska Cancer Center, Biocare and the Sahlgrenska Academy Seminars. During the lunch break between the two lectures, a light lunch is served outside the

Time
12: 15-13: 15

Place
Lecture Hall Arvid Carlsson, Academicum, Medicinaregatan 3

https://translate.google.com/translate?hl=en&sl=sv&u=www.akademiliv.se/seminarier/&prev=search